Point72 Hong Kong LTD Sage Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $141,679 - $205,062	-7,609 Reduced 69.59%	3,325 $62,000
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $186,971 - $243,390	10,934 New	10,934 $236,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $32,363 - $44,676	1,176 Added 13.44%	9,927 $321,000
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $138,839 - $206,654	4,521 Added 106.88%	8,751 $290,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $16,602 - $21,105	-448 Reduced 9.58%	4,230 $180,000
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $188,336 - $268,376	4,678 New	4,678 $207,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $10,691 - $17,777	-412 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $25,836 - $76,313	-988 Reduced 70.57%	412 $12,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $21,063 - $54,169	350 Added 33.33%	1,400 $101,000
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $113,354 - $153,487	808 Added 333.88%	1,050 $147,000
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $38,199 - $44,307	242 New	242 $44,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $49,409 - $84,245	-603 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $57,453 - $70,320	416 Added 222.46%	603 $85,000
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $26,247 - $32,867	187 New	187 $29,000
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $4,068 - $11,211	-67 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $4,113 - $5,930	67	67 $4,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.